GSXAX Mutual Fund Forecast & Price Targets

Compare

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

GSXAX Analyst Rating

Moderate Buy

42 Buy

12 Hold

0 Sell

Based on the consensus analyst ratings on 54 stocks held in GSXAX.

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

GSXAX Analyst Price Target

Average Price Target

$44.16

Based on 54 Wall Street analysts offering 12 month price targets to Aberdeen U.S. Small Cap Equity Fund Class A holdings in the last 3 months. The average price target is $44.16 with a high forecast of $51.73 and a low forecast of $36.59. The average price target represents a 31.18% change from the last price of $33.66.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"29":"$29","52":"$52","34.75":"$34.8","40.5":"$40.5","46.25":"$46.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":51.73,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$51.73</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":44.155,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$44.16</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":36.587,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$36.59</span>\n  </div></div>","useHTML":true}}],"tickPositions":[29,34.75,40.5,46.25,52],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2024","6":"Oct<br/>2024","9":"Jan<br/>2025","12":"Apr<br/>2025","25":"Apr<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,34.49,35.816153846153846,37.142307692307696,38.46846153846154,39.79461538461538,41.12076923076923,42.44692307692308,43.77307692307692,45.09923076923077,46.425384615384615,47.75153846153846,49.0776923076923,50.40384615384615,{"y":51.73,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,34.49,35.23346153846154,35.97692307692308,36.72038461538462,37.463846153846156,38.207307692307694,38.95076923076923,39.69423076923077,40.43769230769231,41.18115384615385,41.924615384615386,42.668076923076924,43.41153846153846,{"y":44.155,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,34.49,34.6513076923077,34.812615384615384,34.97392307692308,35.13523076923077,35.29653846153846,35.457846153846155,35.61915384615385,35.780461538461545,35.94176923076923,36.10307692307693,36.26438461538462,36.42569230769231,{"y":36.587,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":32.23,"date":1711929600000,"info":"<div>Price: <b>$32<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":30.34,"date":1714521600000,"info":"<div>Price: <b>$30<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":31.44,"date":1717372800000,"info":"<div>Price: <b>$31<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":31.59,"date":1719792000000,"info":"<div>Price: <b>$32<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":32.96,"date":1722470400000,"info":"<div>Price: <b>$33<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":32.81,"date":1725321600000,"info":"<div>Price: <b>$33<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":33.68,"date":1727740800000,"info":"<div>Price: <b>$34<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":34.18,"date":1730419200000,"info":"<div>Price: <b>$34<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":38.49,"date":1733097600000,"info":"<div>Price: <b>$38<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":35.69,"date":1735776000000,"info":"<div>Price: <b>$36<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":38.23,"date":1738540800000,"info":"<div>Price: <b>$38<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":35.32,"date":1740960000000,"info":"<div>Price: <b>$35<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":34.49,"date":1743465600000,"info":"<div>Price: <b>$34<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$51.73

Average Price Target$44.16

Lowest Price Target$36.59

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

GSXAX Stocks With Highest Upside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

FOLD

Amicus Therapeutics

6 Buy

2 Hold

0 Sell

Strong Buy

$15.86

xxxxxxxxxxxxxxxxxxxxxxxxxxx

CORT

Corcept Therapeutics

5 Buy

0 Hold

0 Sell

Strong Buy

$134.50

xxxxxxxxxxxxxxxxxxxxxxxxxxx

IAS

Integral Ad Science Holding Corp

5 Buy

5 Hold

0 Sell

Moderate Buy

$12.72

xxxxxxxxxxxxxxxxxxxxxxxxxxx

SM Energy Company

7 Buy

6 Hold

0 Sell

Moderate Buy

$41.54

xxxxxxxxxxxxxxxxxxxxxxxxxxx

FIVN

Five9 Inc

15 Buy

5 Hold

0 Sell

Strong Buy

$43.12

GSXAX Stocks With Highest Downside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

OGS

ONE Gas Inc

2 Buy

4 Hold

0 Sell

Moderate Buy

$76.83

xxxxxxxxxxxxxxxxxxxxxxxxxxx

LRN

Stride, Inc.

3 Buy

1 Hold

0 Sell

Strong Buy

$143.75

xxxxxxxxxxxxxxxxxxxxxxxxxxx

CWST

Casella Waste Systems

4 Buy

1 Hold

1 Sell

Moderate Buy

$124.00

xxxxxxxxxxxxxxxxxxxxxxxxxxx

EAT

Brinker International

3 Buy

9 Hold

0 Sell

Hold

$172.55

xxxxxxxxxxxxxxxxxxxxxxxxxxx

AZEK

AZEK Company Inc

6 Buy

9 Hold

0 Sell

Moderate Buy

$54.00

GSXAX Mutual Fund FAQ

What is GSXAX’s average 12-month price target, according to analysts?

Based on analyst ratings, Aberdeen U.S. Small Cap Equity Fund Class A’s 12-month average price target is 44.16.

What is GSXAX’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for GSXAX, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is GSXAX a Buy, Sell or Hold?

Aberdeen U.S. Small Cap Equity Fund Class A has a consensus rating of Moderate Buy which is based on 42 buy ratings, 12 hold ratings and 0 sell ratings.

What is Aberdeen U.S. Small Cap Equity Fund Class A’s price target?

The average price target for Aberdeen U.S. Small Cap Equity Fund Class A is 44.16. This is based on 54 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $51.73 ,the lowest forecast is $36.59. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about Aberdeen U.S. Small Cap Equity Fund Class A?

Aberdeen U.S. Small Cap Equity Fund Class A’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 54 Wall Streets Analysts.

How can I buy shares of GSXAX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing